{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:33:14Z","timestamp":1779399194591,"version":"3.53.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary biliary cirrhosis (PBC) and psoriasis are frequently observed to co-occur in clinical settings. However, the causal associations and underlying mechanisms between PBC and psoriasis remain poorly defined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we conducted bidirectional MR analysis to explore the causal relationship between PBC and psoriasis using four MR methods: inverse-variance weighted, MR-Egger regression, weighted median, and weighted mode. Sensitivity analyses were carried out, employing different models and testing methods for comparison to assess the influence of heterogeneity and pleiotropy on our findings and to confirm the robustness of these results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A causal relationship between the risk of PBC and psoriasis was identified, as confirmed by IVW analysis (OR: 1.081, 95%CI: 1.028~1.137, <jats:italic>P<\/jats:italic>&amp;lt;0.05). The other three MR methods also produced similar results. However, psoriasis did not have a causal effect on PBC risk (OR: 1.022, 95%CI: 0.935~1.118, <jats:italic>P<\/jats:italic>&amp;gt;0.05). The intercept of MR-Egger regression was 0.0013 (<jats:italic>P<\/jats:italic>&amp;gt;0.05), indicating that genetic pleiotropy did not influence the results. Additionally, the leave-one-out analysis demonstrated the robustness of our MR findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study reveals a causal relationship between PBC and psoriasis, with PBC increasing the risk of psoriasis, but not the reverse. This potential causal relationship offers a new perspective on the etiology of PBC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1264554","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:16:16Z","timestamp":1704341776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Primary biliary cirrhosis and psoriasis: a two-sample Mendelian randomization study"],"prefix":"10.3389","volume":"14","author":[{"given":"Diqian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.06.015","article-title":"The limitations and hidden gems of the epidemiology of primary biliary cirrhosis","volume":"46","author":"Podda","year":"2013","journal-title":"J Autoimmun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9151525","article-title":"The epidemiology of primary biliary cholangitis in European countries: A systematic review and meta-analysis","volume":"2021","author":"Gazda","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J Gastro Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2023.4427","article-title":"Psoriasis vulgaris associated with primary biliary cholangitis: IL-23 links skin manifestations and liver function","volume":"33","author":"Kamura","year":"2023","journal-title":"Eur J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891328","article-title":"Role of TL1A in inflammatory autoimmune diseases: A comprehensive review","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2395","article-title":"Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis","volume":"44","author":"Liu","year":"2012","journal-title":"Nat Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055953","article-title":"Low vitamin D concentrations and BMI are causal factors for primary biliary cholangitis: A mendelian randomization study","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw220","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: Epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12016-017-8649-9","article-title":"Skin manifestations associated with autoimmune liver diseases: a systematic review","volume":"53","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Clinic Rev Allerg Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00005-016-0448-0","article-title":"Primary biliary cholangitis associated with skin disorders: A case report and review of the literature","volume":"65","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Arch Immunol Ther Exp"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.835991","article-title":"Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis","volume":"13","author":"Xu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.hepres.2004.06.003","article-title":"Six cases of primary biliary cirrhosis complicated by psoriasis","volume":"30","author":"Ohira","year":"2004","journal-title":"Hepatol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e13455","DOI":"10.1111\/dth.13455","article-title":"Evaluating the efficacy of ursodeoxycholic acid plus methotrexate vs methotrexate alone in the treatment of moderate to severe plaque-type psoriasis: A randomized clinical trial","volume":"33","author":"Lajevardi","year":"2020","journal-title":"Dermatol Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2230.2007.02401.x","article-title":"Psoriasis treated with ursodeoxycholic acid: three case reports","volume":"32","author":"Itoh","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13555-021-00483-2","article-title":"Interleukin-17 and interleukin-23: A narrative review of mechanisms of action in psoriasis and associated comorbidities","volume":"11","author":"Menter","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.07.005","article-title":"Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis","volume":"64","author":"Qian","year":"2013","journal-title":"Cytokine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00281-022-00950-8","article-title":"How genetic risk contributes to autoimmune liver disease","volume":"44","author":"Ellinghaus","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001030-00003","article-title":"Drug-induced psoriasis: recognition and management","volume":"1","author":"Tsankov","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08904-y","article-title":"Antimitochondrial antibodies: from bench to bedside","volume":"63","author":"Colapietro","year":"2021","journal-title":"Clinic Rev Allerg Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.184218","article-title":"Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.15570\/actaapa.2023.6","article-title":"Primary biliary cholangitis\u2014cause or association with psoriasis: a case report","volume":"32","author":"Tom\u0161e","year":"2023","journal-title":"Acta Dermatovenerol Alpina Pannonica Adriatica"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1264554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:16:18Z","timestamp":1704341778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1264554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2023.1264554"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1264554","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"article-number":"1264554"}}